Skip to main content

Month: January 2024

SPZI: Five New Fully Executed Commodity Contracts; Year to Date Total $303 Million

JP Energy Global, a wholly owned subsidiary of JP 3E Holdings, Inc., formerly Spooz Inc., has successfully closed nine fully executed commodity contracts valued at $303 million for chicken paws CLEARWATER, Fla., Jan. 05, 2024 (GLOBE NEWSWIRE) — JP Energy Global, PTE, LTD, a wholly owned subsidiary of JP 3E Holdings, Inc., formerly Spooz, Inc. (OTC: SPZI), is pleased to announce the execution of nine commodity contracts totaling $303,029,100 for Grade A Chicken Paws. The nine commodity contracts are the cumulative total that includes the previous commodity announced in December 2023. JP Energy Global commands approximately an 18% gross profit margin while minimizing risk since there is no currency risk – all transactions are in US dollars. JP Energy Global does not act as a broker; its business model is to buy and to sell these...

Continue reading

Data Center Cooling Market to Surpass 56145.9 Million by 2030 Drives Due to Rapid Expansion of Cloud Computing

SkyQuest projects that the data center cooling market will attain a value of USD 56145.9 million by 2030, with a CAGR of 17.1% over the forecast period (2023-2030). The rapid expansion of cloud computing and the proliferation of data-intensive applications have ushered in a substantial surge in the demand for data centers. As organizations increasingly migrate their operations to the cloud and rely on data-driven applications, robust and efficient data storage and processing facilities have become paramount in the data center cooling market. Westford, USA, Jan. 05, 2024 (GLOBE NEWSWIRE) — According to SkyQuest, the data center cooling market is on a trajectory of significant growth, driven by an increasing demand for energy-efficient solutions and substantial planned investments. This burgeoning demand has paved the way for promising...

Continue reading

Water Treatment Chemicals Market to Worth USD 40.34 Billion by 2030 | Skyquest Technology

Water treatment chemicals market is segmented on the basis of application, type, end user. By type, the market is segmented into coagulants, ph adjusters & softeners, flocculants, biocides & disinfectants, scale inhibitors & dispersants, corrosion inhibitors, others. By application, market is segmented into raw water treatment, water desalination, cooling, boiler, effluent water treatment, others. By end user, the market is segmented into industrial, municipal, others- Industry forecast 2023-2030 Westford, USA, Jan. 05, 2024 (GLOBE NEWSWIRE) — According to SkyQuest, the water treatment chemicals market expansion can be attributed to the growing demand for various industries such as sugar production, ethanol manufacturing, fertilizer production, geothermal energy generation, and petrochemical manufacturing, particularly...

Continue reading

German American Bank named a Best Bank 2024 by Newsweek

JASPER, Ind., Jan. 05, 2024 (GLOBE NEWSWIRE) — German American Bank recently received recognition by Newsweek as one of America’s Best Regional Banks 2024. This award not only recognizes German American Bank’s exceptional financial performance, yet also the bank’s commitment to helping individuals, families and businesses throughout Indiana and Kentucky communities achieve greater prosperity and quality of life. Newsweek, in partnership with Plant-A Insights Group, conducted an independent review of all of the nation’s regional community banks to name only 250 banks to this prestigious ranking. The study covered various aspects such as profitability, financial relevance, risk exposure to financial uncertainties, and overall health and stability of the financial institution. The analysis also included media reputation monitoring...

Continue reading

Novartis expands production of Pluvicto™ with addition of its largest and most advanced radioligand therapy manufacturing facility in Indianapolis

FDA approval of the company’s second US Radioligand Therapy (RLT) manufacturing facility increases RLT production capacity to 250,000 doses in 2024 and beyondNew 70,000-square foot RLT facility is the company’s largest and most advanced in the world to date and centrally located in the US to maximize access for patients and treatment centersWith four active RLT manufacturing sites and unconstrained supply, Novartis can sufficiently meet current and future demand as ongoing clinical trials may present the potential to bring Pluvicto and Lutathera® to more patients in earlier lines of treatmentNovartis is investigating a broad portfolio of RLTs in advanced cancers including breast, colon, neuroendocrine, lung, pancreatic and prostate to continue meeting global patient needsBasel, January 5, 2024— Novartis announced today that it...

Continue reading

Cassava Sciences Completes Dividend Distribution of Warrants to Shareholders

Shareholders of Record Received Warrants to Purchase Shares of Common Stock Warrants Trade on Nasdaq Under the Ticker “SAVAW” Warrant Holders Who Choose to Exercise During an Early Period Will Receive an Additional 0.5 of a Common Share Per WarrantAUSTIN, Texas, Jan. 05, 2024 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (Nasdaq: SAVA) (“Cassava Sciences” or the “Company”) today announced the completion of a previously announced distribution of warrants (the “Warrants”) to its shareholders. The Warrants now trade on Nasdaq under the ticker SAVAW. Stockholders received four (4) Warrants for each ten (10) shares of the Company’s common stock held as of December 22, 2023 (the “Record Date”), rounded down to the nearest whole number for any fractional warrant. As an example, a shareholder who owned 1,000 shares...

Continue reading

Everything Blockchain Inc. Launches EB Control Enterprise

New offering supports management and reporting capabilities at the enterprise scale Jacksonville, Fla., Jan. 05, 2024 (GLOBE NEWSWIRE) —Everything Blockchain Inc., (OTCMKTS: EBZT), a technology company that is blending blockchain, DBMS and Zero Trust to deliver disruptive new ways to store, manage and protect data, has launched EB Control Enterprise. Expanding upon the celebrated EB Control platform, EB Control Enterprise will feature an enhanced centralized management portal, empowering companies to perform comprehensive enterprise management and reporting on a larger scale. EB Control Enterprise now also plugs seamlessly into enterprise IT workflows such as Active Directory ADFS and adds support for FIDO 2 and SAML. In an era defined by the diligent pursuit of data security and privacy, security professionals are constantly...

Continue reading

Tevogen Bio Inc. and Semper Paratus Acquisition Corporation Announce Effectiveness of Registration Statement for Business Combination

The pro forma equity value of the portion of the combined company attributable to Tevogen Bio Inc (“Tevogen Bio”) stockholders is an expected $1.2 billion. Tevogen Bio is an advanced-stage specialty immunotherapy biotech pioneer developing off-the-shelf, genetically unmodified T cell therapeutics in virology, oncology, and neurology.New York, NY, Jan. 05, 2024 (GLOBE NEWSWIRE) — Tevogen Bio Inc (“Tevogen Bio”), an advanced-stage specialty immunotherapy biotech pioneer and Semper Paratus Acquisition Corporation (“Semper Paratus”) (Nasdaq: LGST, LGSTW), a publicly-traded special purpose acquisition company, today announced that the Securities and Exchange Commission (“SEC”) has declared effective the registration statement on Form S-4 (the “Registration Statement”) filed by Semper Paratus in connection...

Continue reading

Allegro MicroSystems to Present at Needham’s 26th Annual Growth Conference on January 19

MANCHESTER, N.H., Jan. 05, 2024 (GLOBE NEWSWIRE) — Allegro MicroSystems, Inc. (“Allegro”) (Nasdaq: ALGM), a global leader in power and sensing semiconductor solutions for motion control and energy efficient systems, today announced that the Company will present at Needham’s 26th Annual Growth Conference on Friday, January 19, 2024, which is a designated day for virtual presentations and meetings. Vineet Nargolwala, President and Chief Executive Officer, and Derek D’Antilio, Chief Financial Officer, are scheduled to participate in a fireside chat at 12:45 PM EDT. A live and archived webcast of the fireside chat will be available on the Investor Relations page of the Company’s website at www.allegromicro.com. About Allegro MicroSystemsAllegro MicroSystems is a leading global designer, developer, fabless manufacturer and marketer...

Continue reading

Hurco Reports Fourth Quarter and Full Year Results for Fiscal 2023

INDIANAPOLIS, Jan. 05, 2024 (GLOBE NEWSWIRE) — Hurco Companies, Inc. (Nasdaq: HURC) today reported results for the fourth fiscal quarter and fiscal year ended October 31, 2023. Hurco recorded net income of $2,422,000, or $0.36 per diluted share, for the fourth quarter of fiscal 2023, compared to net income of $1,424,000, or $0.22 per diluted share, for the corresponding period in fiscal 2022. For fiscal year 2023, Hurco reported net income of $4,389,000, or $0.66 per diluted share, compared to net income of $8,226,000, or $1.23 per diluted share, for fiscal year 2022. Sales and service fees for the fourth quarter of fiscal 2023 were $66,105,000, an increase of $2,643,000, or 4%, compared to the corresponding prior year period, and included a favorable currency impact of $1,713,000, or 3%, when translating foreign sales to U.S....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.